Two period crossover study to assess the bioavailability of CTP-543 under fed and fasted conditions.
This open-label, single-dose study will assess in healthy subjects a solid oral dose formulation of CTP-543 under fasted and fed conditions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
14
Once daily dosing
Celerion, Inc.
Tempe, Arizona, United States
Measurement of CTP-543 in plasma under fed and fasted conditions
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.